Karen Akinsanya is a Chief Biomedical Scientist, with more than 20 years of hands-on experience in translational science including target selection, validation, early clinical development and business development at Merck & Co. and Ferring Pharmaceuticals. Karen is a Endocrine Physiology PhD from Imperial College London.
LinkedIn: Karen Akinsanya
Company: Schrodinger
For future Invitations to Industry (i2i) talks check here.